EUR 23.6
(1.72%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 266.35 Million EUR | 12.39% |
2022 | 236.99 Million EUR | 19.7% |
2021 | 197.99 Million EUR | -6.03% |
2020 | 210.7 Million EUR | -28.12% |
2019 | 293.14 Million EUR | 2.41% |
2018 | 286.25 Million EUR | 11.22% |
2017 | 257.37 Million EUR | 11.74% |
2016 | 230.33 Million EUR | 52.43% |
2015 | 151.1 Million EUR | 0.6% |
2014 | 150.2 Million EUR | 17.82% |
2013 | 127.48 Million EUR | 14.21% |
2012 | 111.61 Million EUR | 53.59% |
2011 | 72.67 Million EUR | 12.66% |
2010 | 64.5 Million EUR | 22.93% |
2009 | 52.47 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 343.66 Million EUR | 0.0% |
2023 Q4 | 266.35 Million EUR | 0.0% |
2023 Q2 | 220.81 Million EUR | 0.0% |
2023 FY | 266.35 Million EUR | 12.39% |
2022 Q2 | 161.43 Million EUR | 0.0% |
2022 Q4 | 236.99 Million EUR | 0.0% |
2022 FY | 236.99 Million EUR | 19.7% |
2021 Q4 | 197.99 Million EUR | 0.0% |
2021 Q2 | 231.25 Million EUR | 0.0% |
2021 FY | 197.99 Million EUR | -6.03% |
2020 Q2 | 253.33 Million EUR | 0.0% |
2020 FY | 210.7 Million EUR | -28.12% |
2020 Q4 | 210.7 Million EUR | 0.0% |
2019 FY | 293.14 Million EUR | 2.41% |
2019 Q4 | 293.14 Million EUR | 0.0% |
2019 Q2 | 276.02 Million EUR | 0.0% |
2018 Q4 | 286.25 Million EUR | 0.0% |
2018 FY | 286.25 Million EUR | 11.22% |
2018 Q2 | 314 Million EUR | 0.0% |
2017 Q4 | 257.37 Million EUR | 0.0% |
2017 Q2 | 228.17 Million EUR | 0.0% |
2017 FY | 257.37 Million EUR | 11.74% |
2016 FY | 230.33 Million EUR | 52.43% |
2016 Q2 | 165.31 Million EUR | 0.0% |
2016 Q4 | 230.33 Million EUR | 0.0% |
2015 Q4 | 151.1 Million EUR | 0.0% |
2015 FY | 151.1 Million EUR | 0.6% |
2015 Q2 | 177.37 Million EUR | 0.0% |
2014 Q4 | 150.2 Million EUR | 0.0% |
2014 FY | 150.2 Million EUR | 17.82% |
2014 Q2 | 147.15 Million EUR | 0.0% |
2013 Q4 | 127.48 Million EUR | 0.0% |
2013 FY | 127.48 Million EUR | 14.21% |
2013 Q2 | 129.69 Million EUR | 0.0% |
2012 Q3 | - EUR | -100.0% |
2012 Q1 | - EUR | -100.0% |
2012 FY | 111.61 Million EUR | 53.59% |
2012 Q2 | 115.63 Million EUR | 0.0% |
2012 Q4 | 111.61 Million EUR | 0.0% |
2011 FY | 72.67 Million EUR | 12.66% |
2011 Q4 | 72.67 Million EUR | 0.0% |
2011 Q2 | 67.79 Million EUR | 0.0% |
2010 Q4 | 64.5 Million EUR | 0.0% |
2010 FY | 64.5 Million EUR | 22.93% |
2009 FY | 52.47 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Apontis Pharma AG | 57.5 Million EUR | -363.222% |
Dermapharm Holding SE | 2.18 Billion EUR | 87.802% |
Evotec SE | 2.29 Billion EUR | 88.415% |
MERCK Kommanditgesellschaft auf Aktien | 49.12 Billion EUR | 99.458% |
PharmaSGP Holding SE | 131.29 Million EUR | -102.86% |
SynBiotic SE | 34.91 Million EUR | -662.791% |